Syndrome métabolique et diabète chez l'Homme. Composition lipidique et oxydation des lipoprotéines de basse densité (LDL) plasmatiques en relation avec l'activation des plaquettes sanguines.

Abstract : Type-2 diabetes and metabolic syndrome are associated with increased oxidative stress and cardiovascular risk. Platelet hyperactivation and dyslipoproteinemia are two major factors favoring atherothrombosis. We have shown that low-density lipoproteins (LDL) from type-2 diabetic patients activate platelets from healthy volunteers. The primary objective of our study was to establish the lipid and lipid peroxide profile of LDL isolated from plasma of volunteers with a metabolic syndrome (SM), of type-1 (DT-1) or type-2 (DT-2) diabetic patients compared to LDL from healthy volunteers (V). The second objective was to explore their role in platelet activation. Only LDL from MS and DT-2 groups have lipid abnormalities (increased triacylglycerols and decreased cholesteryl esters, decreased linoleic acid). LDL from SM, DT-1 and DT-2 groups show oxidative stress as assessed by increased lipid peroxide derivatives (hydroxylated fatty acids, malondialdehyde) and decreased plasmalogens. Compared to platelets incubated with LDL from the V group, platelets incubated with LDL from other groups are activated as shown by the enhancement of the arachidonic acid signalling cascade (p38 MAPK, cytosolic phospholipase A2, thromboxane B2). Thus, in a pre-diabetic state and in type-2 diabetes, LDL undergo lipid and oxidative modifications and activate platelets. Our results show that lipid peroxides in LDL could be the common denominator underlying platelet hyperactivation.
Document type :
Theses
Biomolecules [q-bio.BM]. INSA de Lyon, 2010. French


https://tel.archives-ouvertes.fr/tel-00587355
Contributor : Evelyne Vericel <>
Submitted on : Wednesday, April 20, 2011 - 11:23:32 AM
Last modification on : Wednesday, April 20, 2011 - 11:27:43 AM

Identifiers

  • HAL Id : tel-00587355, version 1

Collections

HCL | INRA

Citation

Romain Colas. Syndrome métabolique et diabète chez l'Homme. Composition lipidique et oxydation des lipoprotéines de basse densité (LDL) plasmatiques en relation avec l'activation des plaquettes sanguines.. Biomolecules [q-bio.BM]. INSA de Lyon, 2010. French. <tel-00587355>

Export

Share

Metrics

Consultation de
la notice

1519

Téléchargement du document

1378